GMP FGF-8b蛋白,FGF-8b
  • GMP FGF-8b蛋白,FGF-8b
  • GMP FGF-8b蛋白,FGF-8b
  • GMP FGF-8b蛋白,FGF-8b

GMP级别重组人FGF-8b蛋白

价格 询价
包装 100ug 500ug 1000ug
最小起订量 100ug
发货地 北京
更新日期 2025-12-30
微信洽谈

产品详情

中文名称:GMP FGF-8b蛋白英文名称:FGF-8b
品牌: 百普赛斯产地: 北京
保存条件: -20°C to -70°C纯度规格: 99.9%
产品类别: 重组蛋白
货号: FGF-8b用途范围: 科研
规格: 100ug是否进口:
2025-12-30 GMP FGF-8b蛋白 FGF-8b 100ug/RMB;500ug/RMB;1000ug/RMB 百普赛斯 北京 -20°C to -70°C 99.9% 重组蛋白

GMP Human FGF-8b Protein

优势特色(Features

Designed under ISO 9001:2015 and ISO 13485:2016

Manufactured and QC tested under a GMP compliance factory

FDA DMF filed

Animal-Free materials

Beta-lactam materials free

Batch-to-batch consistency

Stringent quality control tests

No animal derived peptone and lactose used in production process

表达区间及表达系统(Source

GMP Human FGF-8b Protein (GMP-FGBH16) is expressed from E. coli cells. It contains AA Gln 23 - Arg 215 (Accession # P55075-3).

蛋白结构(Molecular Characterization

1.jpg

This protein carries no "tag".

The protein has a calculated MW of 22.5 kDa. The protein migrates as 25 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

N端测序(N-terminal Sequence Analysis

Met-Gln-Val-Thr-Val-Gln-Ser-Ser-Pro-Asn-Phe-Thr-Gln-His-Val (Routinely tested).

内毒素(Endotoxin

Less than 10 EU/mg by the LAL method / rFC method.

宿主蛋白残留(Host Cell Protein

0.5 ng/µg of protein tested by ELISA.

宿主核酸残留(Host Cell DNA

0.02 ng/μg of protein tested by qPCR.

无菌(Sterility

The sterility testing was performed by membrane filtration method described in USP<71>and Ph. Eur. 2.6.1.

支原体(Mycoplasma

Negative.

纯度(Purity

>95% as determined by SDS-PAGE.

制剂(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.

Contact us for customized product form or formulation.

运输(Shipping

This product is supplied and shipped with blue ice, please inquire the shipping cost.

存储(Storage

Upon receipt, store it immediately at -20°C or lower for long term storage.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 5 years in lyophilized state;

-70°C for 12 months under sterile conditions after reconstitution.

2.jpg

3.jpg

背景介绍

FGF-8 is a member of the fibroblast growth factor family that was originally discovered as a growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells (1-3). Alternate splicing of mouse FGF-8 mR generates eight secreted isoforms, designated a-h, but only FGF-8a, b, e and f exist in humans (4). FGF-8 contains a 22 amino acid (aa) signal sequence, an Nterminal domain that varies according to the isoform (30 aa for FGF-8b; 20 aa for the shortest, FGF-8a), a 125 aa FGF domain and a 37 aa prolinerich Cterminal sequence. The FGF domain of FGF-8 shares the most aa identity with FGF17 (75%) and FGF-18 (67%), and the three form an FGF subfamily (2). Mouse FGF-8b shares 100% aa identity with human FGF-8b. FGF-8 is widely expressed during embryogenesis, and mediates epithelial-mesenchymal transitions. It plays an organizing and inducing role during gastrulation, and regulates patterning of the midbrain/hindbrain, eye, ear, limbs and heart in the embryo (2, 5 - 8). The isoforms may play different roles in development. FGF-8b shows the strongest receptor affinity and oncogenic transforming capacity although FGF-8a and FGF-8e are also transforming and have been found in human prostate, breast or ovarian tumors (1, 5, 9-12). FGF-8 shows limited expression in the normal adult, but low levels are found in the reproductive and genitourinary tract, peripheral leukocytes and bone marrow hematopoietic cells (3, 9, 13).

ACRO GMP产品制造规范

ACROBiosystems GMP级产品是在质量管理体系下生产的,并符合相关指南:

Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP<92>Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP<1043>Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.

ACROBiosystems质量管理体系内容:

1. 根据ISO 9001:2015ISO 13485:2016进行设计,在GMP工厂进行制造和QC检测

2. 无动物成分

3. QA从批准的供应商处采购的材料

4. ISO 5洁净室和自动灌装设备

5. 人员合格

6. 质量保证审核和批准质量相关文件

7. 全批量生产和控制记录

8. 设备维护和校准

9. 分析程序的验证

10. 进行的稳定性研究

11. 全面的法规支持文件

ACROBiosystems对我们的GMP级产品提供严格的质量控制测试(经过充分验证的设备、工艺和测试方法),以确保它们在纯度、安全性、活性和批间稳定性方面符合严格的标准,每个批量QC批次主要包含以下具体信息:

1. SDS-PAGE

2. 蛋白质含量

3. 内毒素水平

4. 残留宿主细胞DNA含量

5. 残留宿主细胞蛋白质含量

6. 生物活性分析

7. 微生物检测

8. 支原体检测

9. 体外病毒测定

10. 残留水分

11. 批次间一致性

ACRO产品声明

ACROBiosystems GMP级产品专为研究、生产或离体使用而设计。注意:不可直接供人体使用。

关键字: GMP FGF-8b;FGF-8b;FGF-8b蛋白;ACRO;百普赛斯;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。
成立日期 2010-07-22 (16年) 注册资本 8000万人民币
员工人数 500人以上 年营业额 ¥ 1亿以上
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药 经营模式 工厂,试剂
  • 北京百普赛斯生物科技股份有限公司
VIP 3年
  • 公司成立:16年
  • 注册资本:8000万人民币
  • 企业类型:其他股份有限公司(上市)
  • 主营产品:重组蛋白,抗原,抗体,试剂盒
  • 公司地址:北京市北京经济技术开发区宏达北路8号4幢4层
询盘

GMP级别重组人FGF-8b蛋白相关厂家报价

产品名称 价格   公司名称 报价日期
¥2948
VIP5年
上海博尔森生物科技有限公司
2026-01-06
¥2100
VIP7年
上海泽叶生物科技有限公司
2026-01-06
¥24640.00
VIP10年
北京索莱宝科技有限公司
2026-01-06
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.